Abiopharma

🔍 Andreessen Marc L (Executive)

Company: Samsara Inc. (IOT)

Report Date: 2026-06-08

Detailed Transactions and Holdings:

• Sold 531,914 shares of Class A Common Stock at $34.046 per share (Direct)
  Date: 2026-06-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,981,060.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 35,711 shares of Class A Common Stock at $34.7344 per share (Direct)
  Date: 2026-06-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,945,349.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Sold 202 shares of Class A Common Stock at $35.5 per share (Direct)
  Date: 2026-06-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,945,147.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 210,126 shares of Class A Common Stock at $33.3683 per share (Direct)
  Date: 2026-06-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,735,021.00 | transaction_form_type: 4 | Footnotes: F4, F2
• Sold 190,605 shares of Class A Common Stock at $34.1554 per share (Direct)
  Date: 2026-06-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,544,416.00 | transaction_form_type: 4 | Footnotes: F5, F2
• Sold 174,269 shares of Class A Common Stock at $34.9945 per share (Direct)
  Date: 2026-06-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,370,147.00 | transaction_form_type: 4 | Footnotes: F6, F2

Footnotes:

• F1: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $33.46 to $34.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
• F2: These shares are held of record by the LAMA Community Trust, of which the reporting person is a trustee.
• F3: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $34.46 to $35.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
• F4: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $32.70 to $33.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
• F5: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $33.70 to $34.645, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
• F6: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $34.71 to $35.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.